![\"\"](\"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/MHESI-NXPO-hosts-stakeholder-consultation-on-expanding-safety-and-health-claims-assessment-labs_01-1024x683.jpg\")
<\/figure>\n<\/div>\n\n\nDr. Siriporn explained that the consultation aimed to gather input from stakeholders on the current situation, challenges, and opportunities related to expanding food safety and health claims evaluation capacity, particularly in the areas of medical foods and personalized foods. She noted that the global market value of this sector reached over 230 billion THB in 2024, with annual growth of 8\u201310%. In Thailand, the market was valued at 9.5 billion THB domestically and 7 billion THB in exports. With Thailand entering an aging society, demand for specialized foods is expected to grow steadily.<\/p>\n\n\n
![\"\"](\"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/\u0e14\u0e23.\u0e2a\u0e34\u0e23\u0e34\u0e1e\u0e23-03-1-1536x1024-1-1024x683.jpg\")
<\/figure>\n<\/div>\n\n\nDespite this potential, Thailand\u2019s product evaluation system remains limited by the number of accredited agencies and qualified experts, creating bottlenecks in product development, regulatory approval, and commercialization. Dr. Siriporn emphasized that expanding evaluation labs and building expert capacity through training would be key to overcoming these barriers, supporting the growing workload from both industry and research, and raising Thailand\u2019s standards to compete internationally.<\/p>\n\n\n
![\"\"](\"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/MHESI-NXPO-hosts-stakeholder-consultation-on-expanding-safety-and-health-claims-assessment-labs_02-1-1024x683.jpg\")
<\/figure>\n<\/div>\n\n\n\u201cToday\u2019s meeting marks the first step toward drafting policy recommendations to increase evaluation capacity and develop specialized experts suited to Thailand\u2019s needs. This will strengthen the country\u2019s ability to advance innovative food products and enhance long-term economic competitiveness. Today\u2019s insights will lead to actionable recommendations that can drive both policy and practice,\u201d said Dr. Siriporn.<\/p>\n\n\n
![\"\"](\"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/\u0e14\u0e23.-\u0e1e\u0e35\u0e23\u0e1e\u0e07\u0e29\u0e4c-\u0e17\u0e1b\u0e2d-1-1536x1024-2-1024x683.jpg\")
<\/figure>\n<\/div>\n\n\nDr. Peerapong underscored the importance of collective action, stressing that advancing Thailand\u2019s future food industry requires collaboration across sectors. He noted that the session brought together experts in registration processes, providing insights into strategies to accelerate evaluations, thereby improving private sector competitiveness.<\/p>\n\n\n
![\"\"](\"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/\u0e20\u0e01.\u0e40\u0e25\u0e34\u0e28\u0e0a\u0e32\u0e22-01-1-1536x1024-1-1024x683.jpg\")
<\/figure>\n<\/div>\n\n\nThe meeting featured presentations from the Thai FDA by Deputy Secretary-General Mr. Lertchai Lertvut and Ms. Natcha Jankhaikhot, Senior Expert in Food and Drug Affairs.<\/p>\n\n\n\n
Mr. Lertchai discussed global food trends, including the rise of food as medicine, and stressed the need to protect consumers and ensure food safety. He noted that while the FDA has long prioritized these issues, in recent years it has also shifted toward enhancing value creation.<\/p>\n\n\n\n
\u201cThe FDA\u2019s overarching framework is to promote Ease of Doing Business. A central part of this effort is expanding the number of evaluation labs while ensuring efficiency and quality remain uncompromised. The FDA is also revising regulations to better support industry operations and adapt to emerging trends,\u201d Mr. Lertchai explained.<\/p>\n\n\n
![\"\"](\"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/MHESI-NXPO-hosts-stakeholder-consultation-on-expanding-safety-and-health-claims-assessment-labs_03-1-1024x683.jpg\")
<\/figure>\n<\/div>\n\n\nMs. Natcha outlined regulations, registration criteria, and processes for evaluation labs, while highlighting challenges such as strengthening expert capacity, developing professional evaluation systems, integrating evaluation outcomes into policy and organizational development, and fostering expert networks and academic participation.<\/p>\n\n\n
![\"\"](\"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/\u0e14\u0e23.\u0e0a\u0e32\u0e25\u0e34\u0e19\u0e35_Biotech-1-1536x1024-2-1024x683.jpg\")
<\/figure>\n<\/div>\n\n\nIn addition, Dr. Chalinee Kongsawat, Acting Director of the Biosafety Division at the National Center for Genetic Engineering and Biotechnology (BIOTEC), shared BIOTEC\u2019s experience as a safety evaluation unit. She explained that BIOTEC\u2019s biosafety activities focus on developing technical standards, building technical expertise, and providing consulting services. BIOTEC has worked with the FDA to develop standards and expertise for evaluating foods derived from genetically modified organisms (GMOs). Its evaluation scope now includes GMO-derived foods, enzymes, food additives and microbial-based cleaning\/disinfecting products, probiotics, and novel foods from GMOs and cultured animal cells.<\/p>\n\n\n
![\"\"](\"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/\u0e1c\u0e2d.\u0e2a\u0e32\u0e27\u0e2a\u0e34\u0e23\u0e34\u0e19\u0e22\u0e32-01-1-1536x1024-1-1024x683.jpg\")
<\/figure>\n<\/div>\n\n\nThe consultation concluded with a discussion on risk-based product grouping, the development of appropriate evaluation criteria and timelines for each group, capacity-building programs, management models, and a survey to assess future demand for health claims evaluations.<\/p>\n","protected":false},"excerpt":{"rendered":"
On 29 September 2025, NXPO, in collaboration with the F […]<\/p>\n","protected":false},"author":1,"featured_media":39626,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[30],"tags":[2656],"class_list":["post-39625","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","tag-food-safety-en"],"featured_image_src":"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/MHESI-NXPO-hosts-stakeholder-consultation-on-expanding-safety-and-health-claims-assessment-labs.jpg","author_info":{"display_name":"admin","author_link":"https:\/\/www.nxpo.or.th\/th\/author\/adminsti\/"},"jetpack_featured_media_url":"https:\/\/www.nxpo.or.th\/th\/wp-content\/uploads\/2025\/10\/MHESI-NXPO-hosts-stakeholder-consultation-on-expanding-safety-and-health-claims-assessment-labs.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/posts\/39625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/comments?post=39625"}],"version-history":[{"count":1,"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/posts\/39625\/revisions"}],"predecessor-version":[{"id":39639,"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/posts\/39625\/revisions\/39639"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/media\/39626"}],"wp:attachment":[{"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/media?parent=39625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/categories?post=39625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nxpo.or.th\/th\/wp-json\/wp\/v2\/tags?post=39625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}